Genscript Biotech Corporation (HKG:1548)
Hong Kong · Delayed Price · Currency is HKD 12.45
+0.17 (1.38%)
At close: Feb 3, 2026
Genscript Biotech Employees
Genscript Biotech had 5,769 employees as of June 30, 2025. The number of employees increased by 201 or 3.61% since the number was reported on December 31, 2024.
Employees
5,769
Change
201
Growth
3.61%
Revenue / Employee
1.13M HKD
Profits / Employee
4.23M HKD
Market Cap
26.85B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2025 | 5,769 | 201 | 3.61% | 5,769 | 0 |
| Dec 31, 2024 | 5,568 | -1,369 | -19.73% | 5,568 | 0 |
| Dec 31, 2023 | 6,937 | 724 | 11.65% | 6,937 | 0 |
| Dec 31, 2022 | 6,213 | 953 | 18.12% | 6,213 | 0 |
| Dec 31, 2021 | 5,260 | 659 | 14.32% | 5,255 | 5 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Shanghai Henlius Biotech | 3,537 |
| RemeGen | 3,070 |
| Shanghai Junshi Biosciences | 2,670 |
| Zai Lab | 1,869 |
| Keymed Biosciences | 1,469 |
| Biocytogen Pharmaceuticals (Beijing) | 1,306 |
| InnoCare Pharma | 1,176 |
| Everest Medicines | 722 |
Genscript Biotech News
- 2 months ago - Genscript Biotech Corporation (GNNSF) Analyst/Investor Day - Slideshow - Seeking Alpha
- 6 months ago - Genscript Biotech Corporation (GNNSF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 months ago - GenScript Biotech Demonstrates Profitable Scale and Strategic Leadership in H1 2025, Establishing Clear Industry Leadership Through Accelerated Growth and Innovation - PRNewsWire
- 6 months ago - GenScript Biotech's MSCI ESG Rating Upgraded to AA, Recognized as a Global Leader - PRNewsWire
- 7 months ago - China’s drug innovators bank on AI to hasten discovery to commercial success - South China Morning Post
- 11 months ago - Genscript Biotech Corporation 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 11 months ago - Genscript Biotech Corp (GNNSF) (FY 2024) Earnings Call Highlights: Record Profits and Strategic ... - GuruFocus
- 11 months ago - GenScript Biotech Corporation Reports FY 2024 Results - PRNewsWire